MedicarePartD.guide

A non-government resource built from CMS public data

Multiple sclerosis drugs on Blue Cross MedicareRx Basic (S5715-012)

Kesimpta, teriflunomide, dimethyl fumarate and the other MS drugs Part D covers, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Illinois
Premium
$89.70/month
Deductible
$615.00
Change plan

2 of 8 Multiple sclerosis drugs are covered on this plan. All 2 require prior authorization.

6 aren't on the formulary, including teriflunomide and Vumerity.

  • Kesimpta
    ofatumumab
    Covered · prior auth
    $12,016.93
    Tier 5
  • dimethyl fumarate
    generic Tecfidera
    Covered · prior auth
    from $44.01
    Tier 4
Not on the formulary
teriflunomide, Vumerity, fingolimod, Mayzent, Zeposia, Mavenclad

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list